Tom Johnson | Investor Relations |
Stephen Willard | Chief Executive Officer |
Seth Van Voorhees | Chief Financial Officer & Treasurer |
Robert Besthof | Head of Operations & Chief Commercial Officer |
Vernon Bernardino | HC Wainwright |
Good day, and welcome to the NRx Pharmaceuticals Second Quarter 2022 Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Tom Johnson.